Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone modifying activity

SETD1A SETD1B KAT6A SRCAP PRDM2 BAP1 KAT7 KDM2B CDYL PKN1 EP300

1.81e-0622915511GO:0140993
GeneOntologyMolecularFunctionhistone acetyltransferase activity

KAT6A SRCAP KAT7 CDYL EP300

4.65e-05511555GO:0004402
GeneOntologyMolecularFunctionP-type sodium transporter activity

ATP1A1 ATP1A3 ATP12A

5.29e-05101553GO:0008554
GeneOntologyMolecularFunctionP-type sodium:potassium-exchanging transporter activity

ATP1A1 ATP1A3 ATP12A

5.29e-05101553GO:0005391
GeneOntologyMolecularFunctionpeptide-lysine-N-acetyltransferase activity

KAT6A SRCAP KAT7 CDYL EP300

6.72e-05551555GO:0061733
GeneOntologyMolecularFunctionP-type potassium transmembrane transporter activity

ATP1A1 ATP1A3 ATP12A

7.23e-05111553GO:0008556
GeneOntologyMolecularFunctionpeptide N-acetyltransferase activity

KAT6A SRCAP KAT7 CDYL EP300

1.02e-04601555GO:0034212
GeneOntologyMolecularFunctionhistone H3 acetyltransferase activity

KAT6A KAT7 EP300

1.95e-04151553GO:0010484
GeneOntologyMolecularFunctiontranscription factor binding

MAGEA4 SETD1A ZBTB16 PCLO KAT6A APBB2 TWIST2 CRTC1 TACC2 NFIA PKN1 CHD6 PBX1 PBX2 EP300 HTT

2.58e-0475315516GO:0008134
GeneOntologyMolecularFunctionN-acetyltransferase activity

KAT6A SRCAP KAT7 CDYL EP300

3.53e-04781555GO:0008080
GeneOntologyMolecularFunctionextracellular matrix constituent, lubricant activity

MUC17 MUC4

3.56e-0441552GO:0030197
GeneOntologyMolecularFunctionchromatin binding

CHAF1B PCGF2 POLG KAT6A TWIST2 BAP1 KAT7 NFIA GLI2 CDYL PKN1 CHD6 PBX2 EP300 CRAMP1

6.50e-0473915515GO:0003682
GeneOntologyMolecularFunctionhistone H4 acetyltransferase activity

KAT6A KAT7 EP300

7.25e-04231553GO:0010485
GeneOntologyMolecularFunctionN-acyltransferase activity

KAT6A SRCAP KAT7 CDYL EP300

1.20e-031021555GO:0016410
GeneOntologyMolecularFunctionsteroid hormone binding

ATP1A1 ATP1A3

1.23e-0371552GO:1990239
GeneOntologyMolecularFunctionacetyltransferase activity

KAT6A SRCAP KAT7 CDYL EP300

1.31e-031041555GO:0016407
GeneOntologyMolecularFunctionhistone H3K4 monomethyltransferase activity

SETD1A SETD1B

1.63e-0381552GO:0140945
GeneOntologyCellularComponentGolgi lumen

MUC19 MUC16 MUC12 MUC17 ACAN MUC4

1.57e-041091546GO:0005796
GeneOntologyCellularComponentpostsynapse

ABL2 INSYN1 MAP1A GAP43 MAPT PCLO CRTC1 ARHGAP39 MAGEE1 GRM5 RAB3GAP1 CAMKV EIF4G2 GPR156 ATP1A1 ATP1A3 HOMER2 HTT BEGAIN

1.82e-04101815419GO:0098794
GeneOntologyCellularComponentphotoreceptor inner segment membrane

ATP1A1 ATP1A3

3.20e-0441542GO:0060342
HumanPhenoDownturned corners of mouth

PCGF2 PCLO KAT6A TWIST2 SIM1 SRCAP GK GLI2 MAFB ATP1A3

2.28e-061824410HP:0002714
HumanPhenoAbnormality of mouth shape

PCGF2 PCLO KAT6A TWIST2 SIM1 SRCAP BAP1 GK GLI2 MAFB ATP1A3

2.71e-052944411HP:0011338
DomainCadherin_tail

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

4.78e-07371516PF15974
DomainCadherin_CBD

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

4.78e-07371516IPR031904
DomainP-type_ATPase_IIC

ATP1A1 ATP1A3 ATP12A

1.02e-0561513IPR005775
DomainCadherin_2

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.41e-05651516PF08266
DomainCadherin_N

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.41e-05651516IPR013164
DomainN-SET

SETD1A SETD1B

6.49e-0521512PF11764
DomainN-SET

SETD1A SETD1B

6.49e-0521512SM01291
DomainCOMPASS_Set1_N-SET

SETD1A SETD1B

6.49e-0521512IPR024657
DomainCadherin_CS

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

2.58e-041091516IPR020894
DomainATPase_P-typ_TM_dom

ATP1A1 ATP1A3 ATP12A

2.69e-04161513IPR023298
Domain-

ATP1A1 ATP1A3 ATP12A

2.69e-041615131.20.1110.10
DomainCADHERIN_1

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.14e-041131516PS00232
DomainCadherin

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.14e-041131516PF00028
DomainATPase_P-typ_cation-transptr_C

ATP1A1 ATP1A3 ATP12A

3.24e-04171513IPR006068
DomainCation_ATPase_C

ATP1A1 ATP1A3 ATP12A

3.24e-04171513PF00689
DomainCADHERIN_2

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.29e-041141516PS50268
Domain-

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.29e-0411415162.60.40.60
DomainCA

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.45e-041151516SM00112
DomainZnf_RING/FYVE/PHD

PCGF2 ZNF423 PCLO KAT6A BIRC2 DIDO1 RNF126 MAP3K1 ZFPL1 PIKFYVE FGD4 KDM2B

3.61e-0445915112IPR013083
DomainCadherin-like

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.61e-041161516IPR015919
DomainPBC

PBX1 PBX2

3.85e-0441512PF03792
DomainPBX

PBX1 PBX2

3.85e-0441512IPR005542
DomainCation_ATPase_N

ATP1A1 ATP1A3 ATP12A

3.87e-04181513PF00690
DomainZF_ZZ_2

ZZZ3 SQSTM1 EP300

3.87e-04181513PS50135
DomainZF_ZZ_1

ZZZ3 SQSTM1 EP300

3.87e-04181513PS01357
DomainZZ

ZZZ3 SQSTM1 EP300

3.87e-04181513PF00569
DomainCation_ATPase_N

ATP1A1 ATP1A3 ATP12A

3.87e-04181513SM00831
DomainCadherin

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.96e-041181516IPR002126
DomainZnf_ZZ

ZZZ3 SQSTM1 EP300

4.56e-04191513IPR000433
DomainATPase_P-typ_cation-transptr_N

ATP1A1 ATP1A3 ATP12A

4.56e-04191513IPR004014
DomainZnF_ZZ

ZZZ3 SQSTM1 EP300

4.56e-04191513SM00291
DomainHAT_MYST-type

KAT6A KAT7

6.39e-0451512IPR002717
DomainMOZ_SAS

KAT6A KAT7

6.39e-0451512PF01853
DomainMYST_HAT

KAT6A KAT7

6.39e-0451512PS51726
DomainSANT

GON4L ZZZ3 CHD6 CRAMP1

7.08e-04501514SM00717
DomainSEA

MUC16 MUC12 MUC17

7.13e-04221513PF01390
DomainSEA

MUC16 MUC12 MUC17

8.15e-04231513PS50024
DomainSEA_dom

MUC16 MUC12 MUC17

8.15e-04231513IPR000082
DomainSANT/Myb

GON4L ZZZ3 CHD6 CRAMP1

8.22e-04521514IPR001005
Domain-

PCGF2 ZNF423 PCLO KAT6A DIDO1 RNF126 MAP3K1 ZFPL1 PIKFYVE FGD4 KDM2B

1.08e-03449151113.30.40.10
DomainZnf_FYVE_PHD

PCLO KAT6A DIDO1 PIKFYVE FGD4 KDM2B

1.25e-031471516IPR011011
Domain-

ATP1A1 ATP1A3 ATP12A

2.16e-033215133.40.1110.10
Domain-

ATP1A1 ATP1A3 ATP12A

2.16e-033215132.70.150.10
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC12 MUC17 MUC4

5.13e-06161064M27410
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC12 MUC17 MUC4

6.67e-06171064M27412
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC19 MUC16 MUC17 MUC4

1.64e-05211064MM15706
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC12 MUC17 MUC4

2.40e-05231064M556
PathwayREACTOME_DECTIN_2_FAMILY

MUC16 MUC12 MUC17 MUC4

3.97e-05261064M27483
PathwayREACTOME_RHO_GTPASE_CYCLE

ABL2 STBD1 TEX2 ARHGAP39 AKAP12 FGD4 PLEKHG3 PKN1 ARHGAP25 PEAK1 DNMBP PLXNB1

1.11e-0443910612MM15595
PathwayREACTOME_RHO_GTPASE_CYCLE

ABL2 STBD1 TEX2 ARHGAP39 AKAP12 FGD4 PLEKHG3 PKN1 ARHGAP25 PEAK1 DNMBP PLXNB1

1.41e-0445010612M27078
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS

MUC16 MUC12 ADAMTS12 MUC17 MUC4

1.56e-04681065M27303
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

SYNRG SETD1B MAP1A ZNF507 TACC2 CEP192 SRCAP EMSY PIKFYVE ZZZ3 ALMS1 CTR9 SQSTM1 KIAA1217 TNRC6A KDM2B ATP1A1 PATJ DNMBP PCM1 GOLGB1

4.13e-135881592138580884
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

PITPNM2 SETD1A SYNRG SETD1B SPEG POLG KAT6A CEP192 SRCAP ADGRA2 BAP1 PCNX2 PIKFYVE SCAF1 AATK PLEKHM2 TMEM259 PKN1 MICAL3 C3orf18 ZNF579 DNMBP EP300 CRAMP1 ZNF687 HTT

7.39e-1211051592635748872
Pubmed

Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

4.02e-1115159615640798
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SYNRG CHAF1B MAPT TBC1D2 ZNF507 DIDO1 ARHGAP39 EMSY PRDM2 BAP1 SCAF1 NFIA CTR9 EIF4G2 KDM2B PKN1 MICAL3 ZNF579 DNMBP PCM1 ZNF687

7.08e-117741592115302935
Pubmed

Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

9.86e-1117159629911975
Pubmed

CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.47e-1018159615570159
Pubmed

Genomic organization of the family of CNR cadherin genes in mice and humans.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.47e-1018159610662547
Pubmed

Human transcription factor protein interaction networks.

SETD1A ZNF507 GON4L DIDO1 CEP192 SIX4 SRCAP DCAF5 EMSY PRDM2 BAP1 ZZZ3 ALMS1 NFIA SQSTM1 KLF9 GLI2 TNRC6A KDM2B CHD6 ATP1A1 PBX1 PBX2 EP300 PCM1 ZNF687 SP7

3.81e-1014291592735140242
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PITPNM2 SETD1A TEX2 CECR2 ZNF507 DIDO1 CRTC1 PCDHA3 ANKRD50 ADGRA2 BAP1 TNRC6A KDM2B DNMBP CRAMP1 PLXNB1 ZNF687

4.08e-105291591714621295
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

PITPNM2 ZBTB16 DCAF8 MAPT POLG KAT6A TMEM63B APBB2 CEP192 ARHGAP39 PCNX2 PTPRE NFIA PLEKHG3 GLI2 KIAA1217 PKN1 MICAL3 CHD6 PBX1 PATJ PBX2 EP300 CRAMP1 PCM1 GOLGB1 HTT

9.31e-1014891592728611215
Pubmed

Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.04e-0924159624698270
Pubmed

Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

2.88e-0928159615347688
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CDK18 SYNRG ZBTB16 ABL2 MAPT TEX2 LSG1 RANBP3 CRTC1 CEP192 ALMS1 PLEKHG3 SQSTM1 KIAA1217 PEAK1 PATJ DNMBP PCM1 AQR GOLGB1

2.99e-098611592036931259
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

SYNRG MAP1A TEX2 LSG1 CEP192 ALMS1 SQSTM1 TNRC6A MICAL3 PEAK1 PCM1

3.77e-092091591136779422
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

MAP6 TEX2 POLG ZNF507 DIDO1 CRTC1 TACC2 CEP192 ANKRD50 SRCAP DCAF5 AKAP12 PRDM2 KAT7 CTR9 SQSTM1 EIF4G2 PEAK1 PATJ SUCO PLXNB1 GOLGB1

5.36e-0910841592211544199
Pubmed

New nomenclature for chromatin-modifying enzymes.

SETD1A SETD1B KAT6A PRDM2 KAT7 KDM2B EP300

7.98e-0957159718022353
Pubmed

Interaction network of human early embryonic transcription factors.

SETD1A ZNF423 SIX4 EMSY PRDM2 ZZZ3 ALMS1 NFIA KDM2B ATP1A1 PBX1 PBX2 EP300

9.69e-093511591338297188
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MUC19 MUC16 MUC12 MUC17 MUC4

1.53e-0818159518834073
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

PCGF2 ZBTB16 DIDO1 TWIST2 TACC2 SIX4 SIM1 PIKFYVE ZZZ3 NFIA MTF1 SQSTM1 GLI2 PBX1 PBX2 ZNF687 SP7

3.14e-087091591722988430
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

CHAF1B DCAF8 MAP1A MAPT LSG1 CECR2 KAT6A BIRC2 SRCAP DCAF5 KAT7 SCAF1 ZZZ3 IGFBP1 ALMS1 SQSTM1 TNRC6A ZNF579 EP300 PCM1 ZNF687

4.47e-0811161592131753913
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

ZNF507 CRTC1 PRDM2 BAP1 ZZZ3 ALMS1 SQSTM1 TNRC6A KDM2B CHD6 PCM1 GOLGB1 ZNF687

7.49e-084181591334709266
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

ABL2 MAP1A GAP43 MAPT TEX2 PCLO ARHGAP39 MICAL3 ATP1A1 PCM1 HTT BEGAIN

7.73e-083471591217114649
Pubmed

Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.

PCDHA9 PCDHA13 PCDHA8 PCDHA6

1.35e-071115949655502
Pubmed

Proteins of the CNR family are multiple receptors for Reelin.

PCDHA9 PCDHA13 PCDHA8 PCDHA6

2.02e-0712159410612399
Pubmed

Phosphoproteomic analysis of the developing mouse brain.

GAP43 MAPT SYBU ARHGAP39 AKAP12 ENAM CAMKV SQSTM1 PKN1 PCM1

2.21e-072461591015345747
Pubmed

Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

2.49e-0757159632633719
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

SETD1A SYNRG RANBP3 DIDO1 SRCAP EMSY ZZZ3 ALMS1 KDM2B PEAK1 PATJ EP300 PCM1 HTT

2.63e-075491591438280479
Pubmed

CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

2.76e-0758159630377227
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

PITPNM2 SYNRG MAP1A GAP43 MAP6 MAPT TEX2 PCLO TACC2 ARHGAP39 GRM5 RAB3GAP1 CAMKV SQSTM1 KIAA1217 EIF4G2 TNRC6A PEAK1 PCM1 BEGAIN

2.89e-0711391592036417873
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

LSG1 GON4L DIDO1 CRTC1 ARHGAP39 SIX4 EMSY SCAF1 FGD4 PLEKHG3 CTR9 SQSTM1 EIF4G2 TNRC6A KDM2B CDYL CHD6 ZNF579 PATJ DNMBP AQR GOLGB1 ZNF687

3.65e-0714971592331527615
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

LSG1 APBB2 MUC16 CEP192 ANKRD50 AKAP12 LIPE MAVS PLEKHM2 SQSTM1 TNRC6A PKN1 PEAK1 ATP1A1 PCM1 GOLGB1

6.23e-077771591635844135
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

PCGF2 SETD1B KAT6A SRCAP KAT7 KDM2B CHD6 EP300

6.86e-07157159830186101
Pubmed

Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

7.19e-0768159611230163
Pubmed

Multiple genes encode the human Na+,K+-ATPase catalytic subunit.

ATP1A1 ATP1A3 ATP12A

9.31e-07515933035563
Pubmed

Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.

KAT6A KAT7 EP300

9.31e-075159326625199
Pubmed

Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.

KAT6A KAT7 EP300

9.31e-075159317182677
Pubmed

A striking organization of a large family of human neural cadherin-like cell adhesion genes.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.01e-0672159610380929
Pubmed

Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.19e-0674159610817752
Pubmed

The DNA sequence and comparative analysis of human chromosome 5.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.29e-0675159615372022
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

SYBU MAGEE1 AKAP12 PCNX2 PIKFYVE SCAF1 ALMS1 PLEKHM2 CRAMP1

1.39e-06233159937704626
Pubmed

Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.51e-0677159610835267
Pubmed

The family of human Na+,K+-ATPase genes. No less than five genes and/or pseudogenes related to the alpha-subunit.

ATP1A1 ATP1A3 ATP12A

1.86e-06615933036582
Pubmed

Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.89e-0680159610716726
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

SYNRG ABL2 ZNF507 CASP9 CRTC1 CEP192 EMSY ALMS1 MAVS KIAA1217 EIF4G2 TNRC6A MICAL3 ATP1A1 DNMBP PCM1

2.09e-068531591628718761
Pubmed

Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.

SETD1A ABL2 SETD1B GAP43 DCAF5 BAP1 ATP1A1 EP300 GOLGB1

3.10e-06257159930945288
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

CHAF1B KAT6A DIDO1 SRCAP EMSY PRDM2 BAP1 KAT7 NFIA KDM2B CDYL CHD6 RAD23A

4.93e-066081591336089195
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

PITPNM2 ABL2 MAP1A MAP6 PCLO ARHGAP39 GRM5 HOMER2 BEGAIN

6.38e-06281159928706196
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

SYNRG MAP1A LSG1 RANBP3 DIDO1 TACC2 SRCAP EMSY AKAP12 ALMS1 MAVS KIAA1217 EIF4G2 ATP1A1 PCM1 GOLGB1

6.57e-069341591633916271
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

CHAF1B GON4L SRCAP KAT7 ALMS1 SQSTM1 CDYL MICAL3 CHD6 EP300 PCM1 ZNF687 RAD23A

9.26e-066451591325281560
Pubmed

A unique stylopod patterning mechanism by Shox2-controlled osteogenesis.

PBX1 PBX2 SP7

1.10e-0510159327287812
Pubmed

Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation.

MAFB PBX1 PBX2

1.10e-0510159321497760
Pubmed

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

BIRC2 SQSTM1 PBX1 PBX2

1.20e-0531159425996949
Pubmed

Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development.

TWIST2 ACAN SP7

1.51e-0511159319501582
Pubmed

Acetylation of HIV-1 integrase by p300 regulates viral integration.

KAT6A KAT7 EP300

1.51e-0511159316096645
Pubmed

Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.

SETD1A SETD1B KAT7 ZZZ3 DCLRE1C RAD23A

1.88e-05119159623508102
Pubmed

A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

1.88e-05119159628625976
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SETD1B SPEG ZNF423 GON4L CEP192 DCAF5 PLEKHM2 MICAL3 CHD6 AQR

1.96e-054071591012693553
Pubmed

Mutant huntingtin alters Tau phosphorylation and subcellular distribution.

MAPT HTT

2.08e-052159225143394
Pubmed

All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides.

ATP1A1 ATP1A3

2.08e-052159211546672
Pubmed

HBO1 is required for the maintenance of leukaemia stem cells.

KAT6A KAT7

2.08e-052159231827282
Pubmed

Properties and expression of Na+/K+-ATPase α-subunit isoforms in the brain of the swamp eel, Monopterus albus, which has unusually high brain ammonia tolerance.

ATP1A1 ATP1A3

2.08e-052159224391932
Pubmed

Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons.

ATP1A1 ATP1A3

2.08e-052159223761886
Pubmed

MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).

KAT6A EP300

2.08e-052159210824998
Pubmed

Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.

CRTC1 HTT

2.08e-052159222589249
Pubmed

Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.

MUC16 MUC4

2.08e-052159223544943
Pubmed

Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.

MAPT HTT

2.08e-052159225205109
Pubmed

Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.

CRTC1 PIKFYVE

2.08e-052159235275098
Pubmed

The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit.

ATP1A1 ATP1A3

2.08e-05215923030810
Pubmed

Backbone and nearly complete side-chain chemical shift assignments reveal the human uncharacterized protein CXorf51A as intrinsically disordered.

CXorf51A CXorf51B

2.08e-052159234415548
Pubmed

Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease.

GRM5 HTT

2.08e-052159220053912
Pubmed

Localization of Six4/AREC3 in the developing mouse retina; implications in mammalian retinal development.

SIX4 ATP1A1

2.08e-05215929990334
Pubmed

Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.

ATP1A1 ATP1A3

2.08e-052159221498719
Pubmed

Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation.

PBX1 PBX2

2.08e-05215927910944
Pubmed

Aggrecan modulates the expression and phosphorylation of tau in a novel bigenic TauP301L - Acan mouse model.

MAPT ACAN

2.08e-052159232737917
Pubmed

Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.

AKAP12 FGD4

2.08e-052159225356636
Pubmed

Plzf regulates germline progenitor self-renewal by opposing mTORC1.

ZBTB16 CRTC1

2.08e-052159220691905
Pubmed

Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation.

CRTC1 MAP3K1

2.08e-052159218784253
Pubmed

The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.

SETD1A SETD1B

2.08e-052159224550110
Pubmed

Tau Protein Modulates Perineuronal Extracellular Matrix Expression in the TauP301L-acan Mouse Model.

MAPT ACAN

2.08e-052159235454094
Pubmed

Intron-less processed Pcdhalpha genes in the central nervous system.

PCDHA8 PCDHA6

2.08e-052159214697259
Pubmed

An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability.

SETD1B KDM2B

2.08e-052159227106595
Pubmed

Pbx1 is required for adult subventricular zone neurogenesis.

PBX1 PBX2

2.08e-052159227226325
Pubmed

In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F).

SETD1A SETD1B

2.08e-052159238003223
Pubmed

Osterix couples chondrogenesis and osteogenesis in post-natal condylar growth.

ACAN SP7

2.08e-052159225192899
Pubmed

Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.

GRM5 HTT

2.08e-052159224282028
Pubmed

Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice.

GRM5 HTT

2.08e-052159230961637
Pubmed

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer.

MAGEA4 MAGEA9

2.08e-052159219533752
Pubmed

Acetylation Disfavors Tau Phase Separation.

MAPT EP300

2.08e-052159229734651
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

DIDO1 TACC2 KAT7 MAVS CTR9 SQSTM1 PKN1 ZNF579 PCM1 ZNF687 BEGAIN

2.20e-055031591116964243
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

MAP1A TBC1D2 CEP192 ALMS1 SQSTM1 TNRC6A PCM1

2.35e-05184159732908313
Pubmed

Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.

CHAF1B DIDO1 EMSY ZZZ3 CDYL CHD6

2.38e-05124159620850016
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ABL2 STBD1 LSG1 TMEM51 ARHGAP39 ANKRD50 AKAP12 EIF4G2 MICAL3 PEAK1 ATP1A1 PATJ GOLGB1

2.46e-057081591339231216
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

MUC16 PPM1B AATK ZZZ3 KIAA1217 CD300LB EIF4G2 CHD6 ATP1A1 GOLGB1

2.56e-054201591028065597
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

ABL2 TMEM51 APBB2 ANKRD50 AKAP12 KIAA1217 MICAL3 PEAK1 ATP1A1 GOLGB1

2.61e-054211591036976175
Pubmed

Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.

SYNRG STBD1 MUC19 APBB2 AKAP12 MAVS PEAK1 ATP1A1 GOLGB1

2.82e-05339159937232246
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

CHAF1B DIDO1 SIX4 SRCAP EMSY PRDM2 BAP1 KAT7 SCAF1 ZZZ3 NFIA CTR9 EIF4G2 KDM2B CDYL CHD6 EP300 ZNF687

2.84e-0512941591830804502
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

STBD1 ALMS1 SQSTM1 KIAA1217 TNRC6A PEAK1 DNMBP GOLGB1

3.05e-05263159834702444
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

SETD1A STBD1 MAP1A RANBP3 MAGEE1 MAP3K1 AATK SQSTM1 GLI2 PATJ

3.12e-054301591035044719
Pubmed

Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.

TWIST2 GLI2 SP7

3.29e-0514159324076664
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

SETD1A PCGF2 SETD1B KAT6A BIRC2 PPM1B BAP1 ADAMTS12 KAT7 PTPRE ATP1A1 ATP1A3 EP300

3.37e-057301591334857952
InteractionPCDHA3 interactions

PCDHA9 TMEM63B PCDHA8 PCDHA6 PCDHA3 PCDHA1

2.37e-07341586int:PCDHA3
InteractionPCDHA10 interactions

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3

6.57e-07221585int:PCDHA10
InteractionASH2L interactions

SETD1A SETD1B SRCAP EMSY BAP1 RAB3GAP1 ZZZ3 TNRC6A PKN1 EP300 HTT SP7

1.25e-0626515812int:ASH2L
InteractionNFIX interactions

SETD1A SIX4 SRCAP EMSY BAP1 ZZZ3 NFIA SQSTM1 KDM2B ATP1A1 SP7

1.83e-0622715811int:NFIX
InteractionKLF3 interactions

SETD1A ZNF423 EMSY PRDM2 ZZZ3 NFIA SQSTM1 KDM2B CHD6 ATP1A1 EP300

1.91e-0622815811int:KLF3
InteractionAP2A2 interactions

INSYN1 MAPT RNF126 BAP1 SQSTM1 TNRC6A GPR156 ATP1A1 EP300 HTT

3.96e-0619915810int:AP2A2
InteractionSFN interactions

SETD1A SYNRG ABL2 MAP1A MAPT TEX2 RANBP3 CEP192 RNF126 BAP1 KAT7 ALMS1 NFIA PLEKHG3 SQSTM1 PEAK1 DNMBP HTT

8.54e-0669215818int:SFN
InteractionMCRS1 interactions

SETD1A SETD1B INSYN1 KAT6A BAP1 KAT7 ZZZ3 GPR156 PBX2 PCM1

1.70e-0523515810int:MCRS1
InteractionPHF21A interactions

ZNF507 CRTC1 BAP1 ZZZ3 ALMS1 SQSTM1 TNRC6A KDM2B CHD6 PCM1 GOLGB1 ZNF687

1.74e-0534315812int:PHF21A
InteractionTOMM20 interactions

MAPT TEX2 LSG1 POLG BIRC2 TACC2 GK MAVS TNRC6A PEAK1

2.04e-0524015810int:TOMM20
InteractionFEV interactions

SETD1A SIX4 EMSY BAP1 NFIA KDM2B CHD6 PBX2 EP300

3.29e-052031589int:FEV
InteractionPARP1 interactions

SETD1A PCGF2 ZBTB16 MAPT ZNF423 CECR2 DIDO1 SRCAP RNF126 PRDM2 PPM1B BAP1 KAT7 SCAF1 NFIA MTF1 CTR9 SQSTM1 EIF4G2 KDM2B CDYL CHD6 EP300 AQR RAD23A

3.36e-05131615825int:PARP1
InteractionELF4 interactions

SETD1A SRCAP EMSY BAP1 ZZZ3 KDM2B ZNF687

3.44e-051151587int:ELF4
InteractionPCDHA6 interactions

PCDHA8 PCDHA6 PCDHA3

3.84e-0591583int:PCDHA6
InteractionPCDHA1 interactions

PCDHA8 PCDHA3 PCDHA1

3.84e-0591583int:PCDHA1
InteractionFBXO42 interactions

MAP1A TACC2 CEP192 PIKFYVE ALMS1 SQSTM1 TNRC6A ATP1A1 PCM1 GOLGB1

3.90e-0525915810int:FBXO42
InteractionAP2B1 interactions

SYNRG MAPT CEP192 BAP1 RAB3GAP1 CFAP54 AATK ALMS1 SQSTM1 TNRC6A EP300 HTT

3.95e-0537315812int:AP2B1
InteractionZFAND6 interactions

BIRC2 SQSTM1 PKN1 RAD23A

4.05e-05251584int:ZFAND6
InteractionKDM6A interactions

SETD1A SETD1B BAP1 ZZZ3 NFIA MAFB HTT SP7

4.25e-051621588int:KDM6A
InteractionKDM1A interactions

MAPT ZNF507 BIRC2 CRTC1 PRDM2 BAP1 ZZZ3 ALMS1 PLEKHG3 SQSTM1 KIAA1217 TNRC6A KDM2B CHD6 EP300 PCM1 GOLGB1 ZNF687 HTT SP7

4.87e-0594115820int:KDM1A
InteractionPFN1 interactions

SYNRG MAP1A TEX2 PCLO CEP192 BAP1 ALMS1 SQSTM1 KIAA1217 MICAL3 PEAK1 DNMBP GOLGB1 HTT

4.97e-0550915814int:PFN1
InteractionYWHAH interactions

CDK18 SYNRG ABL2 MAPT TEX2 LSG1 RANBP3 SPEG CRTC1 CEP192 BAP1 ALMS1 PLEKHG3 SQSTM1 KIAA1217 PEAK1 PATJ DNMBP SUCO PCM1 AQR HTT

5.07e-05110215822int:YWHAH
InteractionATP1B2 interactions

MAPT ATP1A1 ATP1A3 HTT

5.55e-05271584int:ATP1B2
InteractionNUCKS1 interactions

CECR2 KAT6A DIDO1 SRCAP EMSY BAP1 KAT7 EP300 HTT

6.15e-052201589int:NUCKS1
InteractionELF1 interactions

SETD1A SRCAP EMSY BAP1 ZZZ3 NFIA ZNF687

6.16e-051261587int:ELF1
InteractionFIS1 interactions

STBD1 TEX2 LSG1 RAB3GAP1 GK MAVS SQSTM1 ATP12A HTT

6.37e-052211589int:FIS1
InteractionFHL2 interactions

SETD1A MAGEA9 ZBTB16 EMSY BAP1 ZZZ3 ALMS1 KIAA1217 PATJ PBX2 EP300 HTT

7.02e-0539615812int:FHL2
InteractionPCDHA8 interactions

PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

7.05e-05551585int:PCDHA8
InteractionTLX1 interactions

KAT6A SIX4 BAP1 NFIA KDM2B PBX1 PBX2 EP300

7.33e-051751588int:TLX1
InteractionTOP3B interactions

PITPNM2 SETD1A SYNRG SETD1B SPEG POLG KAT6A CEP192 SRCAP ADGRA2 BAP1 PCNX2 PIKFYVE SCAF1 AATK PLEKHM2 TMEM259 PKN1 MICAL3 C3orf18 ZNF579 DNMBP EP300 CRAMP1 ZNF687 HTT

7.60e-05147015826int:TOP3B
InteractionCREBBP interactions

SETD1A MAPT KAT6A CRTC1 TACC2 SRCAP BAP1 NFIA MTF1 EIF4G2 PBX1 EP300 HTT SP7 RAD23A

7.68e-0559915815int:CREBBP
InteractionGSK3A interactions

SYNRG DCAF8 MAP1A MAPT TEX2 LSG1 CEP192 ALMS1 SQSTM1 TNRC6A MICAL3 PEAK1 PCM1

7.74e-0546415813int:GSK3A
InteractionCNOT9 interactions

MAGEA9 PCDHA3 CEP192 AATK ALMS1 SQSTM1 GLI2 TNRC6A PCM1

8.94e-052311589int:CNOT9
InteractionCCDC6 interactions

SYNRG CEP192 ZNF835 BAP1 PIKFYVE KIAA1217 TNRC6A ATP1A1 DNMBP EP300

8.94e-0528615810int:CCDC6
InteractionRERE interactions

SETD1A SETD1B KAT6A ZZZ3 EP300 SP7

9.17e-05931586int:RERE
InteractionYWHAZ interactions

CDK18 SYNRG CHAF1B ABL2 MAP6 MAPT TEX2 SPEG KAT6A CRTC1 TACC2 CEP192 MAP3K1 BAP1 CAMKV PLEKHG3 SQSTM1 PEAK1 ATP1A1 DNMBP SUCO EP300 PCM1 HTT

9.64e-05131915824int:YWHAZ
InteractionGOLGA1 interactions

CEP192 RAB3GAP1 ALMS1 SQSTM1 PEAK1 DNMBP PCM1 GOLGB1

1.00e-041831588int:GOLGA1
InteractionCASP2 interactions

MAPT KAT6A BIRC2 CASP9 HTT

1.07e-04601585int:CASP2
InteractionCARD8 interactions

CASP9 CEP192 SRCAP ZZZ3 PEAK1

1.07e-04601585int:CARD8
InteractionVASP interactions

SYNRG MAP1A CRTC1 CEP192 ALMS1 SQSTM1 TNRC6A PEAK1 PATJ DNMBP

1.12e-0429415810int:VASP
InteractionHOMER3 interactions

CDK18 CEP192 GRM5 PKN1 PATJ HOMER2 HTT

1.20e-041401587int:HOMER3
InteractionHOMER1 interactions

INSYN1 MAPT GRM5 BAP1 PATJ HOMER2 HTT

1.20e-041401587int:HOMER1
InteractionPTPN1 interactions

STBD1 DCAF8 MAPT TEX2 LSG1 TACC2 ARHGAP39 ZFPL1 RAB3GAP1 GK MAVS C3orf18 ATP1A1 SUCO EP300

1.23e-0462515815int:PTPN1
InteractionTRAF1 interactions

CDK18 ZBTB16 MAP6 BIRC2 MAVS SQSTM1 KIAA1217 PKN1 PBX1 PBX2

1.43e-0430315810int:TRAF1
InteractionSTX4 interactions

STBD1 TEX2 LSG1 TMEM51 APBB2 ZFPL1 RAB3GAP1 TNRC6A MICAL3 PEAK1 ATP1A1 GOLGB1

1.46e-0442815812int:STX4
InteractionNCOA6 interactions

SETD1A SETD1B TNRC6A MAFB EP300 HTT SP7

1.49e-041451587int:NCOA6
InteractionKLF12 interactions

SETD1A EMSY PRDM2 ZZZ3 NFIA KDM2B CHD6 EP300

1.50e-041941588int:KLF12
InteractionPAX6 interactions

RANBP3 SIX4 SRCAP BAP1 NFIA KDM2B MAFB CHD6 PBX1 PATJ EP300

1.52e-0436615811int:PAX6
InteractionPCDHA2 interactions

DIDO1 PCDHA8 NFIA

1.62e-04141583int:PCDHA2
InteractionGSK3B interactions

SYNRG MAP1A MAPT TEX2 LSG1 BIRC2 CEP192 MAP3K1 TXNRD1 ALMS1 SQSTM1 TNRC6A MICAL3 CHD6 DMBT1 PEAK1 PCM1 SP7

1.62e-0486815818int:GSK3B
InteractionMAD2L1 interactions

SETD1A ABL2 KAT6A SRCAP DCAF5 ZZZ3 EIF4G2 CDYL PEAK1

1.72e-042521589int:MAD2L1
InteractionE2F1 interactions

BIRC2 RNF126 DCAF5 EMSY PRDM2 BAP1 ZZZ3 EP300

1.85e-042001588int:E2F1
InteractionCRAMP1 interactions

MAGEA9 GON4L MAGEE1 CRAMP1

1.96e-04371584int:CRAMP1
InteractionGOLGA2 interactions

CDK18 ZBTB16 RANBP3 ZNF835 ZFPL1 AATK ZZZ3 DCLRE1C NFIA SQSTM1 KIAA1217 KDM2B PKN1 EP300 PCM1 GOLGB1

2.15e-0473315816int:GOLGA2
InteractionSTX7 interactions

SYNRG STBD1 MAPT TEX2 LSG1 TMEM51 APBB2 AKAP12 ZFPL1 BAP1 MICAL3 PEAK1 ATP1A1 GOLGB1 HTT

2.18e-0465915815int:STX7
InteractionKANSL2 interactions

SETD1A SETD1B INSYN1 ZZZ3 GPR156

2.23e-04701585int:KANSL2
InteractionRHOT2 interactions

STBD1 TEX2 LSG1 TACC2 GK AATK ALMS1 MAVS KIAA1217 SP7

2.29e-0432115810int:RHOT2
InteractionEN1 interactions

DCAF5 BAP1 NFIA KDM2B PBX2 EP300

2.31e-041101586int:EN1
InteractionELF2 interactions

SETD1A ZNF507 SRCAP EMSY BAP1 NFIA SP7

2.34e-041561587int:ELF2
InteractionCPVL interactions

PCGF2 BAP1 PTPRE KLF9 GLI2 TNRC6A SP7

2.34e-041561587int:CPVL
InteractionH3C14 interactions

SETD1A CHAF1B SETD1B KAT6A KDM2B PKN1 EP300

2.34e-041561587int:H3C14
InteractionGPR88 interactions

TMEM259 ATP1A3 ATP12A

2.46e-04161583int:GPR88
InteractionYY1 interactions

SETD1A PCGF2 GON4L DIDO1 SRCAP EMSY BAP1 ZZZ3 NFIA KLF9 EP300 ZNF687

2.51e-0445415812int:YY1
InteractionSASS6 interactions

INSYN1 TBC1D2 CEP192 ALMS1 SQSTM1 TNRC6A PCM1

2.63e-041591587int:SASS6
InteractionING5 interactions

KAT6A KAT7 CTR9 EP300 PCM1 HTT

2.80e-041141586int:ING5
InteractionTRAF2 interactions

CDK18 PCGF2 ZBTB16 RANBP3 BIRC2 MAP3K1 ZZZ3 MAVS SQSTM1 KIAA1217 EIF4G2 PKN1 EP300 RAD23A

2.92e-0460315814int:TRAF2
InteractionCASP8 interactions

MAPT BIRC2 CASP9 BAP1 MAVS SQSTM1 ATP1A3 HTT

2.92e-042141588int:CASP8
InteractionHAP1 interactions

CDK18 ZNF835 KAT7 PKN1 PCM1 HTT

2.94e-041151586int:HAP1
InteractionCMC1 interactions

MAVS EP300 HTT

2.97e-04171583int:CMC1
InteractionFXR1 interactions

MAGEA4 CDK18 MAPT ZNF423 CECR2 DIDO1 TACC2 BAP1 MAFB CDYL KAZN HOMER2 EP300 PCM1 GOLGB1

3.00e-0467915815int:FXR1
InteractionAFDN interactions

MAPT CEP192 ARHGAP39 BAP1 KIAA1217 TNRC6A PEAK1 PATJ DNMBP GOLGB1

3.06e-0433315810int:AFDN
InteractionPXN interactions

ABL2 CEP192 AATK ALMS1 SQSTM1 KIAA1217 TNRC6A PEAK1 DNMBP GOLGB1

3.14e-0433415810int:PXN
InteractionTACR3 interactions

DCAF5 RAB3GAP1 MAVS ATP1A3 ATP12A

3.28e-04761585int:TACR3
InteractionHNF4A interactions

SETD1A MUC19 SRCAP EMSY BAP1 ZZZ3 NFIA KDM2B EP300

3.29e-042751589int:HNF4A
InteractionJADE1 interactions

MAPT RANBP3 KAT6A KAT7 SQSTM1

3.49e-04771585int:JADE1
InteractionCRNDE interactions

BIRC2 DMBT1

3.63e-0441582int:CRNDE
InteractionCAMK2A interactions

MAPT GRM5 EMSY BAP1 SQSTM1 EIF4G2 PATJ HTT RAD23A

3.66e-042791589int:CAMK2A
InteractionELK3 interactions

SETD1A EMSY BAP1 NFIA KDM2B CHD6

3.70e-041201586int:ELK3
InteractionCEP85 interactions

CEP192 MAP3K1 ALMS1 SQSTM1 GLI2 TNRC6A PCM1

3.80e-041691587int:CEP85
InteractionBRD1 interactions

CHAF1B DCAF8 MAP1A KAT6A BIRC2 KAT7 SQSTM1 ZNF579 PCM1 ZNF687

3.96e-0434415810int:BRD1
InteractionCSNK2B interactions

PCGF2 DCAF8 KAT6A DIDO1 RNF126 BAP1 KAT7 CAMKV CTR9 CDYL MICAL3 EP300 ZNF687 SP7

4.18e-0462515814int:CSNK2B
InteractionNUP43 interactions

SETD1A SETD1B MUC19 GON4L SRCAP EMSY PRDM2 SCAF1 ZZZ3 MAVS NFIA EIF4G2 CHD6 ZNF687

4.18e-0462515814int:NUP43
InteractionPCDHA11 interactions

PCDHA9 PCDHA3 PCDHA1

4.18e-04191583int:PCDHA11
InteractionRBBP5 interactions

SETD1A SETD1B EMSY RAB3GAP1 ZZZ3 TNRC6A MAFB PKN1 EP300

4.49e-042871589int:RBBP5
InteractionSIX4 interactions

GOLGA6L2 SIX4 NFIA SP7

4.59e-04461584int:SIX4
InteractionWWTR1 interactions

SYNRG DIDO1 SRCAP EMSY ZZZ3 ALMS1 PEAK1 PATJ EP300 PCM1 HTT

5.11e-0442215811int:WWTR1
InteractionBLZF1 interactions

CDK18 ZBTB16 RANBP3 ZZZ3 PKN1 HTT

5.21e-041281586int:BLZF1
InteractionCEP152 interactions

MAPT CEP192 ALMS1 SQSTM1 GLI2 TNRC6A PCM1

5.36e-041791587int:CEP152
Cytoband1p36.21

TMEM51 CASP9 PRDM2 PLEKHM2 KAZN

2.80e-066315951p36.21
Cytoband5q31

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

3.23e-0611515965q31
CytobandEnsembl 112 genes in cytogenetic band chr5q31

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

6.33e-042981596chr5q31
GeneFamilyCD molecules|Mucins

MUC19 MUC16 MUC12 MUC17 MUC4

1.19e-07211065648
GeneFamilyClustered protocadherins

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

2.00e-0664106620
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

KAT6A KAT7 EP300

1.25e-04171063486
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

ZZZ3 SQSTM1 EP300

1.50e-0418106391
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

GON4L ZZZ3 CHD6 CRAMP1

2.62e-04531064532
GeneFamilyATPase Na+/K+ transporting subunits

ATP1A1 ATP1A3

7.01e-04710621208
GeneFamilyWD repeat domain containing|Caspase recruitment domain containing|Apoptosome

BIRC2 CASP9 MAVS

7.09e-04301063959
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

SETD1A SETD1B PRDM2

1.03e-03341063487
GeneFamilyMAGE family

MAGEA4 MAGEA9 MAGEE1

1.65e-034010631136
GeneFamilyZinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases

KAT6A KAT7

3.87e-0316106266
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

MAPT CASP9 CEP192 GRM5 AATK

4.27e-031811065694
GeneFamilyWD repeat domain containing|DDB1 and CUL4 associated factors

DCAF8 DCAF5

4.90e-03181062498
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

FGD4 PLEKHG3 DNMBP

6.86e-03661063722
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ZBTB16 ZNF423 TWIST2 AKAP12 NFIA KLF9 GLI2 KAZN PBX1

3.45e-081951589ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass

STBD1 MAPT AKAP12 ADAMTS12 NFIA MICAL3 PEAK1 PBX1

4.26e-0719115883379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCellNS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC16 TACC2 NFIA KIAA1217 EIF4G2 ATP1A1 MUC4 PCM1

6.03e-07200158864462a18afca3c1a8548a857924b8166058bf958
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PCLO MUC16 KIAA1217 ATP1A1 PBX1 MUC4 PLXNB1 GOLGB1

6.03e-072001588ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellfacs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F TMEM51 GK PTPRE PLEKHG3 CDYL ATP1A3

1.51e-0615715870ad242320ada7bcb9e29548d3050bf4fd3a07115
ToppCellfacs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F TMEM51 GK PTPRE PLEKHG3 CDYL ATP1A3

1.51e-061571587fe4c9556806203e57522d1986754ebe5a20aa2de
ToppCellfacs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F TMEM51 PCNX2 GK FGD4 MAFB ATP1A3

1.71e-0616015877217730ae14840b935b3bf9aa49becbcbcd8a682
ToppCellfacs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F TMEM51 PCNX2 GK FGD4 MAFB ATP1A3

1.71e-061601587317ef81460c1a31b51119a6309b11be6a8d4ea3e
ToppCellfacs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F TMEM51 PCNX2 GK FGD4 MAFB ATP1A3

1.71e-061601587e6191240c93da34fc4431a35ef496edf323cb41e
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INSYN1 MAP1A PCLO PCNX2 CAMKV PBX2 BEGAIN

3.48e-061781587a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INSYN1 MAP1A PCLO PCNX2 CAMKV PBX2 BEGAIN

3.48e-0617815871bddbc083c36657bd6910f7466126ab325e88176
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAP43 MAP6 MAPT PCDHA3 SYBU MAGEE1 ATP1A3

4.17e-06183158791764095f7ea4bc806ef6c7b841fc5e5e90faf5f
ToppCellTCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9

ABL2 ZNF423 ADGRA2 ADAMTS12 GLI2 ACAN PEAK1

4.64e-0618615871e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCellAdult|World / Lineage, Cell type, age group and donor

TBC1D2 TMEM63B TACC2 GK PTPRE FGD4 DMBT1

5.16e-0618915875cd285bfad973125d46d704fec18b21266a63379
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor

ZNF423 TWIST2 GRM5 AKAP12 GLI2 KAZN PBX1

5.34e-0619015877dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CHAF1B MAP1A MUC16 MUC12 DNAH12 MUC4 PCM1

5.34e-0619015870adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCellrenal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

PITPNM2 ZBTB16 APBB2 SYBU SIM1 FGD4 KLF9

5.34e-061901587f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CHAF1B MAP1A MUC16 MUC12 DNAH12 MUC4 PCM1

5.34e-06190158705455775845f4ded5c27e7b83242078d23162aaf
ToppCellCOVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type

PRTG PCLO TMEM63B TACC2 ESYT3 DMBT1 PATJ

5.53e-061911587276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCellMesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor

ZNF423 TWIST2 AKAP12 IGSF10 NFIA GLI2 KAZN

5.72e-061921587a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ZNF423 TWIST2 AKAP12 IGSF10 GLI2 KAZN PBX1

5.92e-0619315879ab47b360bee1d4f1092c2269e58acebe9584021
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADGRA2 AKAP12 ADAMTS12 GLI2 KIAA1217 KAZN PBX1

6.12e-061941587cf0244a29934e515446ac917d3c30672b460fb04
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PCLO SIM1 FGD4 TMEM72 KAZN ATP1A1 PATJ

6.12e-06194158793c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADGRA2 AKAP12 ADAMTS12 GLI2 KIAA1217 KAZN PBX1

6.12e-061941587ba7f971fb9a19423602da60770f23d9fead4a451
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

TACC2 CFAP54 DNAH12 NFIA KIAA1217 PBX1 MUC4

6.33e-061951587fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

TACC2 CFAP54 DNAH12 NFIA KIAA1217 PBX1 MUC4

6.33e-061951587eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABL2 GK PTPRE FGD4 CD300LB MAFB EP300

6.55e-06196158701cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

ZBTB16 TWIST2 AKAP12 ADAMTS12 IGSF10 GLI2 PBX1

6.55e-061961587bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP1A MAP6 CCDC190 MUC16 DNAH12 MUC4 PCM1

6.77e-06197158791637bdeab85024b5a02d1066f76cb803a2d6420
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster

GAP43 MAPT PCLO GRM5 CAMKV KAZN PBX1

6.77e-06197158779b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP1A MAP6 CCDC190 MUC16 DNAH12 MUC4 PCM1

6.77e-06197158722c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP1A MAP6 CCDC190 MUC16 DNAH12 MUC4 PCM1

6.77e-0619715873bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster

GAP43 MAPT PCLO GRM5 CAMKV KAZN PBX1

6.77e-061971587d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP1A MAP6 CCDC190 MUC16 DNAH12 MUC4 PCM1

6.77e-06197158787db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 TWIST2 SYBU IGFBP1 GLI2 KIAA1217 PLXNB1

6.99e-0619815875cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CACNA1F CECR2 GK LIPE ATP1A1 PATJ PLXNB1

6.99e-061981587285f729140b1df029c24f6ca1d2438470ac51794
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 TWIST2 SYBU IGFBP1 GLI2 KIAA1217 PLXNB1

6.99e-061981587ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 TWIST2 SYBU IGFBP1 GLI2 KIAA1217 PLXNB1

6.99e-0619815875375a2895cf995f0db4a61861093f01794707901
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MUC16 TWIST2 SYBU IGFBP1 GLI2 KIAA1217 PLXNB1

6.99e-06198158735edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.

GAP43 MAPT PCLO CAMKV NFIA KAZN ATP1A3

6.99e-061981587d81f35c0066558ff96dd06f58fca72cd82e681e8
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP6 CCDC190 MUC16 DNAH12 MUC4 PCM1 GOLGB1

6.99e-061981587d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type.

GAP43 MAPT PCLO SYBU CAMKV ATP1A3 PBX1

7.23e-0619915871029f3458b7fda464aa0e7ef06e081e2618c1388
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type.

GAP43 MAPT PCLO SYBU CAMKV ATP1A3 PBX1

7.23e-0619915878a04398653a1794921d73a6a950c1fb6fdf68c85
ToppCellNeuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster

GAP43 MAP6 MAPT PCLO SYBU CAMKV PBX1

7.23e-061991587058373b4ac3cec2108cb24265628ff0a50646e33
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PCLO KIAA1217 ATP1A1 PBX1 MUC4 PLXNB1 GOLGB1

7.47e-06200158797f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellTracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 NFIA GLI2 KIAA1217 ATP12A PBX1 HOMER2

7.47e-062001587682960e28542a3d6c119047cd0131941932cfdea
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type.

GAP43 MAPT PCLO SYBU CAMKV ATP1A3 PBX1

7.47e-062001587c248233b004f8ef0bab3c65ecfe295887966f2ee
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster

GAP43 MAP6 MAPT PCLO SYBU CAMKV PBX1

7.47e-062001587db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster

GAP43 MAP6 MAPT PCLO SYBU CAMKV PBX1

7.47e-06200158730a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCellE18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass

PCDHA8 PCDHA3 PCDHA1 MAGEE1 AKAP12 ZNF687

2.23e-051591586b4bc888e978b1b577721b891b0af6ba9a1607044
ToppCellfacs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM51 ARHGAP39 GK FGD4 CD300LB ATP1A3

2.48e-051621586484ea4ac40de672dcbd2583a52cb7f385c918814
ToppCellfacs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM51 ARHGAP39 GK FGD4 CD300LB ATP1A3

2.48e-051621586bba144ac5332bab9eba2ccf599703c781a7f88f1
ToppCellCiliated_cells-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id

MAP1A MAP6 TCP11 MUC16 DNAH12 GPR156

2.48e-0516215865319603f7ba3f48126dcf2ba9ae604be11bf2577
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass

ZBTB16 MAPT PCDHA8 PCDHA3 LIPE FGD4

2.57e-051631586f1ec2625b52664308968b01d8e0275e1e0751480
ToppCelldroplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PITPNM2 SYBU AATK ARHGAP25 KAZN ATP1A3

2.94e-051671586a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor

PITPNM2 PRTG CECR2 SIX4 KIAA1217 PATJ

3.25e-051701586269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MUC16 SIX4 KIAA1217 ATP12A MUC4 HOMER2

3.59e-051731586464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCellAdult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor

CHAF1B SYBU NFIA KIAA1217 ATP12A MUC4

4.21e-05178158635a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 KIAA1217 ATP12A PATJ MUC4 GOLGB1

4.34e-0517915866e965e424eebef50f0202cff75f458be395cfca1
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CDK18 GAP43 MAP6 SPEG TWIST2 BEGAIN

4.34e-051791586f5bb4d3a27d56698473219970e764084096cc582
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CDK18 GAP43 MAP6 SPEG TWIST2 BEGAIN

4.34e-051791586fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCellCiliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

MAP1A CCDC190 MUC16 DNAH12 ATP12A MUC4

4.48e-051801586d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCellControl-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations)

TACC2 PTPRE KIAA1217 ATP1A1 PATJ MUC4

4.62e-051811586c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

MUC16 SYBU KIAA1217 ATP12A MUC4 HOMER2

4.76e-0518215863f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCelldroplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAPT TWIST2 IGSF10 AATK DMBT1 HOMER2

4.91e-051831586dc9602bed3136db91faeffef177006246dc92743
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor

PITPNM2 PRTG CECR2 KIAA1217 PATJ MUC4

5.21e-051851586673f0c688ae6984bc8027df2da335787924f4137
ToppCelldroplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STBD1 SPEG TMEM51 TMEM215 PLEKHG3 PLXNB1

5.21e-05185158630df02fbe2828e3c4f3e5c4cda855e74fb31be39
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

TACC2 NFIA KIAA1217 PATJ MUC4 HOMER2

5.21e-051851586cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

MAP1A MAP6 CCDC190 MUC16 CFAP54 DNAH12

5.21e-051851586f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ZBTB16 TACC2 SYBU FGD4 ATP1A1 PATJ

5.53e-0518715865df9e1f5ca32217af255e76e6fb5afa346337811
ToppCellCOVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type

CECR2 APBB2 SIM1 TMEM72 KAZN ATP1A1

5.70e-051881586df1fd0819d301679f3c9ea404e942e39095912eb
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor

PRTG CECR2 TACC2 ESYT3 KAZN DMBT1

5.87e-051891586dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCellwk_15-18-Epithelial-PNS-PCP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GAP43 MAP6 MAPT SYBU CAMKV ATP1A3

5.87e-05189158622c927d2691b867fbdee1fbee042a6d3f7eadd7d
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PITPNM2 FGD4 MICAL3 KAZN PATJ HOMER2

5.87e-0518915868c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PITPNM2 FGD4 MICAL3 KAZN PATJ HOMER2

5.87e-0518915865d902a4660a27548764bf04c6de152b565da835c
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

ZBTB16 TACC2 FGD4 KLF9 ATP1A1 GOLGB1

5.87e-051891586a48df46274d51e84ffb40264646de7346104efb9
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

MAPT PCLO GRM5 IGSF10 ATP1A1 ATP1A3

6.04e-0519015866e92c78799f34b31d098854503c796edb0dc7f80
ToppCellCOVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations)

MUC16 KIAA1217 ATP12A PATJ MUC4 HOMER2

6.04e-05190158651ca9ef4df3220487152fcf684147730637c7cc1
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-0519115867b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCellPCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

GAP43 MAP6 MAPT SYBU CAMKV ATP1A3

6.22e-0519115863a5081dc542ac6262acfe5f8084a86616fee8082
ToppCellBAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-0519115869f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-051911586fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCellControl-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class

MAP6 CCDC190 MUC16 DNAH12 MUC4 PLXNB1

6.22e-051911586ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TWIST2 AKAP12 ADAMTS12 KLF9 GLI2 PBX1

6.22e-0519115861caf726bd07fdca389e678fc16304a6ef1790423
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-051911586b4e335e798c9617356b8e24412f9270c42dce656
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-051911586c4b223b33c020a064f576711a3d700eb60a2d737
ToppCellBAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-051911586df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCellControl-Epithelial|Control / Disease group,lineage and cell class （2021.01.30）

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-051911586b78547dae8328244a47c83346447bdd787efbcae
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TWIST2 AKAP12 ADAMTS12 KLF9 GLI2 PBX1

6.22e-0519115863d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCellControl-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30）

MAP6 CCDC190 MUC16 TACC2 DNAH12 MUC4

6.22e-051911586cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCellControl-Epithelial|Control / Condition, Lineage and Cell class

MAP6 CCDC190 MUC16 DNAH12 MUC4 PLXNB1

6.22e-0519115866228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TWIST2 AKAP12 ADAMTS12 KLF9 GLI2 PBX1

6.40e-0519215864022f208eb5db760abd0aac782a25e8ab63efc64
ToppCell368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

PCLO ADGRA2 AKAP12 PTPRE PLEKHG3 PKN1

6.40e-051921586b016e229300c183e14c0e2bba494bf49c7899112
ToppCell368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

PCLO ADGRA2 AKAP12 PTPRE PLEKHG3 PKN1

6.40e-051921586ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAP43 MAPT PCLO IGSF10 CAMKV ATP1A3

6.40e-051921586fe9297cb65234d9f511bab1a5dbf2679d5a4cd15
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ZBTB16 TMEM63B TACC2 SYBU ATP1A1 PATJ

6.40e-05192158629f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPEG TMEM51 TMEM215 AATK ACAN PLXNB1

6.40e-051921586eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TWIST2 AKAP12 ADAMTS12 KLF9 GLI2 PBX1

6.40e-0519215869333aba0d04203ccccad78d82bf6359922f810a7
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor

ZNF423 TWIST2 AKAP12 GLI2 KAZN PBX1

6.40e-051921586d21f0f577156f17c899b08871046a26b88aea011
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAP43 MAPT PCLO IGSF10 CAMKV ATP1A3

6.59e-051931586a189d46c39067b717509cd144e0225cc93d7731d
DrugEthacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A

SYNRG RANBP3 PCLO DIDO1 CRTC1 MTF1 SQSTM1 ACAN ARHGAP25 HTT BEGAIN

7.55e-08187157111565_UP
Drug5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA

PCGF2 RANBP3 APBB2 CASP9 SRCAP MAP3K1 TMEM259 MAFB PATJ PCM1

1.06e-0619515710903_UP
DrugDyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

PCGF2 DCAF8 POLG CASP9 PCDHA6 SRCAP PRDM2 RAB3GAP1 ALMS1 PCM1

1.11e-06196157107022_DN
DrugChlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A

MAPT KAT6A TBC1D2 APBB2 SYBU ZFPL1 PRDM2 CAMKV EIF4G2 KAZN

1.22e-06198157101541_UP
DrugMephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A

SETD1A APBB2 ZFPL1 PRDM2 AJAP1 PTPRE KLF9 KAZN PATJ PCM1

1.33e-06200157103425_UP
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

SYNRG KAT6A DIDO1 TACC2 SYBU PRDM2 PPM1B CDYL EP300

4.58e-0618015794541_DN
DrugLithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A

PCGF2 ZBTB16 PCLO APBB2 CRTC1 KLF9 MAFB MICAL3 C3orf18

6.24e-0618715792571_UP
Drug5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA

APBB2 GON4L SRCAP MAP3K1 PRDM2 ALMS1 KLF9 PATJ PCM1

8.40e-061941579955_UP
DrugMetyrapone [54-36-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A

PCGF2 MAPT RANBP3 APBB2 ZFPL1 ALMS1 PLEKHG3 PATJ PCM1

8.76e-0619515795667_DN
DrugEthosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A

CDK18 ABL2 TBC1D2 APBB2 SYBU SRCAP TMEM259 KAZN PATJ

9.13e-0619615792280_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

RANBP3 APBB2 GON4L TMEM259 PLEKHG3 SQSTM1 MAFB MICAL3 AQR

9.13e-0619615794819_DN
Drugestradiol, USP; Down 200; 0.01uM; MCF7; HG-U133A

SYNRG APBB2 CEP192 PRDM2 ADAMTS12 AATK ACAN CDYL PLXNB1

9.90e-061981579121_DN
DrugDomperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A

PCGF2 MAPT RANBP3 APBB2 SYBU PTPRE MTF1 TMEM259 KLF9

1.03e-0519915795701_DN
DrugNSC89595

CASP9 PIKFYVE ATP1A1 ATP1A3 ATP12A

4.59e-05571575CID000002464
Drugouabagenin

ATP1A1 ATP1A3 ATP12A

5.10e-05111573CID000010497
Druganacardic acid

KAT6A BIRC2 KAT7 EP300

5.19e-05301574CID000167551
Drugpioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A

CDK18 GAP43 TBC1D2 PRDM2 SQSTM1 KAZN PEAK1 PATJ

5.58e-0519115785977_UP
DrugQuercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

DCAF8 TEX2 KAT6A SRCAP PLEKHG3 KLF9 PCM1 AQR

6.00e-0519315784846_DN
DrugHomochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A

PCGF2 RANBP3 KAT6A CASP9 TMEM259 MAFB KAZN PCM1

6.22e-0519415785998_DN
DrugBetonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A

CDK18 TBC1D2 SRCAP TMEM259 MAFB C3orf18 ATP1A3 PLXNB1

6.45e-0519515783642_UP
DrugPhenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; PC3; HT_HG-U133A

PCDHA6 ADGRA2 PRDM2 LIPE AJAP1 SQSTM1 ACAN PLXNB1

6.69e-0519615785758_UP
DrugColistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A

SETD1A PCGF2 RANBP3 TMEM51 ZFPL1 BAP1 PLEKHM2 AQR

6.69e-0519615782851_DN
DrugDiphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A

SETD1A PCGF2 POLG GON4L SRCAP PCNX2 MAFB AQR

6.69e-0519615781494_UP
DrugPyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A

SETD1A PCDHA9 MAPT DIDO1 ALMS1 PLEKHM2 TMEM259 PCM1

6.69e-0519615782751_DN
DrugRibavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A

MAP1A GAP43 RANBP3 PCLO KAT6A TBC1D2 SRCAP C3orf18

6.69e-0519615786018_UP
DrugTriamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A

SYNRG POLG TBC1D2 SRCAP RNF126 PCNX2 MTF1 PLEKHG3

6.69e-0519615781819_DN
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A

RANBP3 SPEG APBB2 GON4L CRTC1 PLEKHM2 MICAL3 PATJ

6.69e-0519615784539_DN
DrugThiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A

RANBP3 CRTC1 SRCAP AKAP12 ZFPL1 PRDM2 ACAN PLXNB1

6.69e-0519615787479_UP
Drugbenserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A

PCGF2 TEX2 POLG GON4L DIDO1 TMEM259 ACAN HTT

6.69e-051961578631_DN
DrugLisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A

PCGF2 DCAF8 RANBP3 ALMS1 MTF1 SQSTM1 PKN1 GOLGB1

6.69e-0519615785504_DN
DrugHymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A

CDK18 RANBP3 POLG TBC1D2 CRTC1 PCDHA6 MICAL3 AQR

6.69e-0519615783383_DN
DrugIoversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A

CDK18 SPEG TBC1D2 CASP9 SYBU SRCAP AJAP1 MAFB

6.93e-0519715783365_DN
Druggenistein; Up 200; 10uM; PC3; HG-U133A

PCGF2 ABL2 LSG1 RANBP3 TMEM51 AATK CAMKV BEGAIN

6.93e-051971578703_UP
DrugIsoconazole [27523-40-6]; Down 200; 9.6uM; HL60; HG-U133A

MAP1A APBB2 PRDM2 PPM1B PTPRE KLF9 ACAN PCM1

6.93e-0519715781372_DN
DrugBambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A

SETD1A ABL2 RANBP3 SYBU SRCAP MAP3K1 PCNX2 PCM1

6.93e-0519715787239_UP
DrugIfosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A

SETD1A PCGF2 PCDHA9 POLG MAP3K1 ZFPL1 KLF9 PCM1

6.93e-0519715786279_UP
DrugAcebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A

SETD1A KAT6A CRTC1 ALMS1 TMEM259 ACAN EIF4G2 KAZN

7.18e-0519815781493_UP
DrugPHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A

DCAF8 POLG APBB2 PTPRE DCLRE1C PLEKHM2 CDYL PATJ

7.18e-0519815787076_UP
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A

SETD1B KAT6A DIDO1 PCDHA6 AKAP12 MAP3K1 ALMS1 AQR

7.18e-0519815784367_DN
Drugchlorpropamide; Down 200; 100uM; MCF7; HG-U133A

ABL2 GAP43 APBB2 CASP9 SRCAP PRDM2 ADAMTS12 ACAN

7.18e-051981578144_DN
DrugOndansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A

SETD1A CASP9 SRCAP MAP3K1 TMEM259 PLEKHG3 KLF9 CDYL

7.18e-0519815786270_UP
DrugRiluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A

SETD1A CHAF1B PCGF2 RANBP3 CASP9 PLEKHM2 TMEM259 HTT

7.18e-0519815782334_DN
DrugAntipyrine [60-80-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A

ZNF423 TMEM51 SRCAP PTPRE PLEKHM2 SQSTM1 PATJ PCM1

7.44e-0519915781489_DN
DrugCP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A

MAPT ZNF423 ZFPL1 PLEKHG3 ACAN DMBT1 PCM1 BEGAIN

7.44e-0519915787532_UP
DrugNoscapine [128-62-1]; Up 200; 9.6uM; MCF7; HT_HG-U133A

KAT6A TBC1D2 CRTC1 ADGRA2 ZFPL1 KLF9 MAFB KAZN

7.44e-0519915782745_UP
DrugFluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A

ZNF423 PCLO KAT6A SRCAP EMSY ZFPL1 PCNX2 MAFB

7.44e-0519915783839_UP
Drugdopamine hydrochloride; Down 200; 1uM; MCF7; HG-U133A

SETD1A CEP192 RNF126 PRDM2 AATK AJAP1 ALMS1 CAMKV

7.44e-051991578491_DN
DrugBephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A

CDK18 MAP1A RANBP3 ZFPL1 ADAMTS12 AJAP1 TMEM259 KAZN

7.44e-0519915786466_UP
DrugKarakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A

SETD1A MAP1A RANBP3 SRCAP EMSY BAP1 DMBT1 PLXNB1

7.44e-0519915784297_DN
DrugRibavirin [36791-04-5]; Down 200; 16.4uM; PC3; HT_HG-U133A

SETD1B POLG SRCAP EMSY ZFPL1 PTPRE CDYL PCM1

7.44e-0519915787316_DN
DrugHomochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A

SETD1A PCGF2 MAP1A TBC1D2 SQSTM1 MICAL3 PEAK1 PCM1

7.44e-0519915782386_DN
DrugBenzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A

PCGF2 RANBP3 APBB2 AJAP1 ALMS1 TMEM259 PATJ PCM1

7.44e-0519915781679_UP
Drugretinoic acid; Up 200; 1uM; PC3; HT_HG-U133A

KAT6A SRCAP MAP3K1 ZFPL1 ALMS1 GLI2 MUC4 BEGAIN

7.44e-0519915784435_UP
DrugGabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A

SETD1B RANBP3 APBB2 SRCAP MAP3K1 PRDM2 C3orf18 PCM1

7.44e-0519915782731_DN
DrugPapaverine hydrochloride [61-25-6]; Down 200; 10.6uM; PC3; HT_HG-U133A

ABL2 DCAF8 SPEG APBB2 SRCAP RNF126 BAP1 C3orf18

7.44e-0519915785769_DN
DrugKhellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A

CHAF1B PCGF2 ABL2 CRTC1 ZFPL1 PRDM2 ACAN HOMER2

7.70e-0520015781922_UP
DrugThiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A

CDK18 RANBP3 APBB2 DIDO1 EMSY MAP3K1 PRDM2 MAFB

7.70e-0520015781704_UP
DrugPergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

SETD1A PCDHA9 TMEM51 APBB2 GON4L AKAP12 MICAL3 AQR

7.70e-0520015787031_UP
DrugEpiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A

PCGF2 RANBP3 APBB2 CASP9 SRCAP TMEM259 MAFB PATJ

7.70e-0520015785687_DN
DrugNSC-84513

MAVS ATP1A1 ATP1A3

1.38e-04151573CID000256927
DrugMethamphetamine

MAGEA4 MAP1A GAP43 MAPT RANBP3 SPEG KAT6A GON4L TACC2 SIX4 GRM5 EMSY PRDM2 AJAP1 PLEKHM2 TMEM259 SQSTM1 EIF4G2 TNRC6A MICAL3 ATP1A1 GOLGB1

2.54e-04140115722ctd:D008694
DrugG226 compound

CASP9 SQSTM1

2.81e-0441572ctd:C000600490
DrugAC1L1G5B

KAT6A CASP9 KAT7 EP300

2.83e-04461574CID000003531
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

SYNRG ABL2 DIDO1 EMSY PRDM2 DMBT1 PCM1

2.86e-0418315771206_UP
DrugRetinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

SETD1A PCLO APBB2 CASP9 SYBU PBX1 PATJ

3.05e-0418515776243_UP
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

MAPT PCDHA6 SYBU SRCAP MAP3K1 SQSTM1 PATJ

3.15e-0418615776996_UP
DrugForskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A

SETD1A PCGF2 TACC2 AKAP12 PLEKHM2 SQSTM1 DMBT1

3.36e-0418815777104_UP
Drug0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A

ABL2 KAT6A DIDO1 SRCAP MAP3K1 PRDM2 ACAN

3.59e-0419015773733_UP
DrugSulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A

SYNRG MAPT TBC1D2 APBB2 GON4L MAP3K1 ALMS1

3.59e-0419015773373_DN
DrugPiperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A

PCGF2 MAP1A MAPT SRCAP PLEKHM2 TMEM259 PBX1

3.70e-0419115774247_DN
DrugSanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A

SYNRG POLG PCLO PIKFYVE ALMS1 PLEKHM2 MICAL3

3.70e-0419115774168_DN
DrugPiretanide [55837-27-9]; Up 200; 11uM; HL60; HT_HG-U133A

PCGF2 ZBTB16 APBB2 PCNX2 KLF9 ACAN MUC4

3.82e-0419215776144_UP
DrugRemoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A

PCGF2 RANBP3 PCLO PRDM2 PCNX2 PLEKHG3 EIF4G2

3.94e-0419315773124_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

SETD1A PCGF2 RANBP3 TMEM51 RNF126 PLEKHM2 TMEM259

3.94e-0419315771667_DN
DrugY-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA

SETD1A RANBP3 APBB2 CRTC1 MAP3K1 RAB3GAP1 PATJ

3.94e-041931577948_UP
DrugEthynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

SETD1B DCAF8 RANBP3 KAT6A CRTC1 PLEKHM2 MICAL3

3.94e-0419315775024_DN
DrugDiphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SYNRG EMSY MAP3K1 PCNX2 PTPRE SQSTM1 PATJ

3.94e-0419315777447_DN
DrugCyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A

PCLO KAT6A APBB2 EMSY AKAP12 PRDM2 AJAP1

4.07e-0419415774411_DN
DrugDropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A

GON4L EMSY CAMKV TMEM259 PLEKHG3 C3orf18 BEGAIN

4.07e-0419415775531_UP
Drug0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A

PCGF2 CRTC1 RNF126 PLEKHM2 TMEM259 GLI2 PLXNB1

4.07e-0419415774331_DN
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

SETD1A APBB2 CRTC1 TMEM259 PLEKHG3 KLF9 C3orf18

4.07e-0419415773422_UP
Drug2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A

SETD1B DCAF8 PRDM2 BAP1 AATK ZZZ3 SQSTM1

4.07e-0419415771209_DN
DrugMethapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A

MAPT SYBU SRCAP RNF126 ZFPL1 PATJ PCM1

4.07e-0419415774990_DN
DrugRolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A

RNF126 RAB3GAP1 TMEM259 PLEKHG3 MAFB EP300 PLXNB1

4.07e-0419415775330_DN
DrugAcetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A

PCDHA9 RANBP3 GON4L EMSY ZFPL1 MICAL3 PATJ

4.07e-0419415775384_DN
DrugCP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A

SETD1B MAP1A PCLO KAT6A EMSY ADAMTS12 ACAN

4.07e-0419415773906_UP
DrugBenzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

POLG CASP9 EMSY AKAP12 CAMKV TMEM259 PLEKHG3

4.07e-0419415773169_DN
DrugLeucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A

SYNRG DCAF8 MAPT SRCAP AKAP12 KLF9 KAZN

4.07e-0419415776767_DN
DrugIndapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A

PCGF2 ABL2 DCAF8 SRCAP KAZN PATJ HOMER2

4.07e-0419415774335_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A

DCAF8 MAPT RANBP3 SRCAP AKAP12 MAP3K1 ZFPL1

4.07e-0419415776778_DN
DrugCyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A

MAP1A MAPT APBB2 GON4L AATK KAZN PCM1

4.07e-0419415774470_DN
DrugS(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A

SPEG TBC1D2 ZFPL1 PRDM2 AJAP1 PATJ PCM1

4.19e-0419515773393_DN
DrugPiribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A

PCGF2 RANBP3 SRCAP RNF126 ZFPL1 PATJ PCM1

4.19e-0419515773512_DN
DrugPhenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A

PCGF2 MAPT RANBP3 EMSY KAZN PLXNB1 BEGAIN

4.19e-0419515773802_DN
Drug2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A

PCGF2 MAP1A POLG DIDO1 TMEM259 GLI2 PBX1

4.19e-0419515771214_UP
DrugCarbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A

RANBP3 CRTC1 PCDHA6 TMEM259 KAZN PATJ PCM1

4.19e-0419515775399_DN
DrugFlumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A

AKAP12 ZFPL1 LIPE TMEM259 KAZN DMBT1 BEGAIN

4.19e-0419515773712_UP
DrugDiphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A

ABL2 DIDO1 PCNX2 SQSTM1 EIF4G2 KAZN PCM1

4.19e-0419515777318_UP
DrugMyosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A

POLG TBC1D2 ZFPL1 ADAMTS12 AATK PLEKHG3 PCM1

4.19e-0419515773737_DN
DrugCiprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A

PCGF2 RANBP3 RNF126 PLEKHG3 KLF9 KAZN PLXNB1

4.19e-0419515771522_DN
Disease1,5 anhydroglucitol measurement

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 RAB3GAP1

1.56e-10291587EFO_0008009
Diseaseneuroticism measurement, cognitive function measurement

PCDHA9 PCLO ZNF507 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 SYBU SIM1 GRM5 SCAF1 AATK ZZZ3 KIAA1217 TNRC6A

7.29e-0856615816EFO_0007660, EFO_0008354
Diseaseneutrophil count

PCDHA9 ZBTB16 TIMD4 MAPT LSG1 ZNF423 CCDC190 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 AKAP12 AATK SQSTM1 TNRC6A MAFB ARHGAP25 ATP1A1 ATP1A3 PBX1 HTT SP7

1.37e-06138215823EFO_0004833
Diseasefamilial hemiplegic migraine (implicated_via_orthology)

ATP1A1 ATP1A3 ATP12A

5.19e-0671583DOID:0060178 (implicated_via_orthology)
Diseasesevere acute respiratory syndrome, COVID-19

MAPT CECR2 CRTC1 PCDHA6 ADAMTS12 HCG22 AJAP1 NFIA GLI2 KIAA1217 PBX1 PATJ

5.66e-0644715812EFO_0000694, MONDO_0100096
Diseasevisceral adipose tissue measurement, body mass index

PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1

7.57e-06871586EFO_0004340, EFO_0004765
Diseasevital capacity

PCDHA9 ZBTB16 MAPT TCP11 RANBP3 PCLO PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 SIX4 MAP3K1 NFIA MTF1 ACAN MICAL3 PBX1 PATJ HOMER2

1.07e-05123615820EFO_0004312
Diseasepost-traumatic stress disorder

INSYN1 MAPT TBC1D2 PCDHA8 PCDHA6 PCDHA3 PCDHA1 KAZN

1.41e-052021588EFO_0001358
Diseaseneurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology)

SETD1A SETD1B

2.85e-0521582DOID:0070417 (implicated_via_orthology)
Diseaseleft ventricular function, response to anthracycline-based chemotherapy

PRDM2 KAZN

2.85e-0521582EFO_0004295, EFO_0005257
Diseaseneutrophil count, basophil count

PCDHA9 ZBTB16 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 SP7

2.95e-052241588EFO_0004833, EFO_0005090
Diseasenervous system disease (implicated_via_orthology)

ATP1A1 ATP1A3 ATP12A

3.20e-05121583DOID:863 (implicated_via_orthology)
Diseasepost-traumatic stress disorder symptom measurement

PCDHA8 PCDHA6 PCDHA3 PCDHA1 CAMKV

8.09e-05821585EFO_0008535
Diseaseurate measurement, bone density

CHAF1B TBC1D2 CRTC1 SIM1 AKAP12 GLI2 EIF4G2 ARHGAP25 KAZN DMBT1 PEAK1 PBX1

1.34e-0461915812EFO_0003923, EFO_0004531
DiseaseHypoplastic Left Heart Syndrome

PCDHA9 PCDHA13

2.82e-0451582C0152101
DiseaseAutosomal Dominant Parkinsonism

MAPT POLG ATP1A3

4.47e-04281583C0752098
DiseaseAutosomal Dominant Juvenile Parkinson Disease

MAPT POLG ATP1A3

4.47e-04281583C0752097
DiseaseParkinsonism, Experimental

MAPT POLG ATP1A3

4.47e-04281583C0752101
DiseaseAutosomal Recessive Parkinsonism

MAPT POLG ATP1A3

4.47e-04281583C0752100
DiseaseFamilial Juvenile Parkinsonism

MAPT POLG ATP1A3

4.47e-04281583C0752104
DiseaseRamsay Hunt Paralysis Syndrome

MAPT POLG ATP1A3

4.47e-04281583C0242423
DiseasePARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE

MAPT POLG ATP1A3

4.47e-04281583C1868675
DiseaseParkinsonism, Juvenile

MAPT POLG ATP1A3

5.50e-04301583C0752105
DiseaseParkinsonian Disorders

MAPT POLG ATP1A3

5.50e-04301583C0242422
Diseasegrowth differentiation factor 15 measurement

CRTC1 HCG22

5.88e-0471582EFO_0009181
DiseaseParkinson's disease (is_implicated_in)

MAPT POLG CASP9 HTT

7.52e-04761584DOID:14330 (is_implicated_in)
DiseaseFEV/FEC ratio

CHAF1B DCAF8 TIMD4 TCP11 SPEG CRTC1 MAP3K1 PPM1B KAT7 DNAH12 ACAN MAFB MICAL3 DMBT1 PBX2 HOMER2

9.46e-04122815816EFO_0004713
DiseaseBladder Neoplasm

MAGEA9 PRDM2 BAP1 CHD6 EP300

9.64e-041401585C0005695
DiseaseMalignant neoplasm of urinary bladder

MAGEA9 PRDM2 BAP1 CHD6 EP300

9.95e-041411585C0005684
DiseaseOsteitis Deformans

SQSTM1 ZNF687

1.00e-0391582C0029401
Diseaseepilepsy (is_implicated_in)

POLG ATP1A3

1.00e-0391582DOID:1826 (is_implicated_in)
DiseaseBehavioral variant of frontotemporal dementia

MAPT SQSTM1

1.00e-0391582C4011788
Diseasethyroxine measurement

CXorf51A CXorf51B DIDO1 SIM1

1.05e-03831584EFO_0005130
DiseaseAbnormality of refraction

PCDHA9 MAPT PCLO PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 NFIA TMEM72 PEAK1

1.05e-0367315811HP_0000539
Diseasesnoring measurement

MAPT SIM1 GRM5 CRAMP1

1.09e-03841584EFO_0008341
Diseasebone density

CHAF1B MAPT TACC2 MAFB ARHGAP25 DMBT1 PATJ SP7

1.21e-033881588EFO_0003923
Diseasemean platelet volume

PITPNM2 ZBTB16 SETD1B TEX2 CRTC1 SRCAP DCAF5 FGD4 CTR9 KLF9 GYS2 TNRC6A PBX1 HTT

1.22e-03102015814EFO_0004584
Diseasebody weight

ZNF423 GON4L CRTC1 PCDHA1 CEP192 SIM1 AATK DNAH12 ACAN KIAA1217 TNRC6A MAFB CDYL KAZN PATJ PCM1

1.25e-03126115816EFO_0004338
Diseaseinterventricular septum thickness

MAPT KDM2B

1.25e-03101582EFO_0009287
Diseasepulse pressure measurement

PCDHA9 GAP43 TEX2 ZNF423 PCDHA13 PCDHA8 PCDHA6 PCDHA3 PCDHA1 SRCAP RNF126 PLEKHM2 MTF1 KLF9 KIAA1217 TNRC6A PCM1

1.33e-03139215817EFO_0005763
Diseasemiddle cerebral artery infarction (biomarker_via_orthology)

GAP43 MAPT CASP9 CRTC1

1.60e-03931584DOID:3525 (biomarker_via_orthology)
Diseaseneutrophil percentage of leukocytes

ZBTB16 MAPT LSG1 EMSY AATK SQSTM1 KDM2B MAFB ARHGAP25 HTT

1.72e-0361015810EFO_0007990
Diseaseepilepsy (implicated_via_orthology)

MAPT CDYL ATP1A1 ATP1A3 ATP12A

1.89e-031631585DOID:1826 (implicated_via_orthology)
DiseaseMalignant neoplasm of breast

MAGEA4 BIRC2 TACC2 SIX4 SIM1 MAGEE1 EMSY AKAP12 MAP3K1 BAP1 LIPE EP300 PLXNB1 GOLGB1

1.97e-03107415814C0006142
Diseaseneurotic disorder

MAPT PCLO GRM5 AATK

2.16e-031011584EFO_0004257
DiseaseBell's palsy

CXorf51A CXorf51B EIF4G2 PATJ

2.24e-031021584EFO_0007167
DiseaseTourette syndrome

PITPNM2 INSYN1 MUC16

2.46e-03501583EFO_0004895
Diseasecortical thickness

PITPNM2 PRTG ZBTB16 GAP43 MAPT ZNF423 TACC2 SYBU ADGRA2 MAP3K1 NFIA TNRC6A MICAL3 HOMER2

2.72e-03111315814EFO_0004840
Diseasemyelodysplastic syndrome (implicated_via_orthology)

POLG BAP1

2.86e-03151582DOID:0050908 (implicated_via_orthology)
Diseasebreast cancer (is_marker_for)

MAPT CASP9 MAP3K1 KAT7 IGFBP1

3.26e-031851585DOID:1612 (is_marker_for)
Diseasepyruvate measurement

GAP43 SYBU GK GLI2 ACAN KIAA1217

3.30e-032681586EFO_0010117
Diseaseheart disease (biomarker_via_orthology)

CASP9 EP300

3.68e-03171582DOID:114 (biomarker_via_orthology)
DiseaseHuntington Disease

GAP43 HTT

3.68e-03171582C0020179
DiseaseStevens-Johnson syndrome, toxic epidermal necrolysis

HCG22 MAFB

3.68e-03171582EFO_0004276, EFO_0004775
Diseaseabnormal paneth cell measurement

ZBTB16 MAFB

4.59e-03191582EFO_0007963
Diseasebody fat percentage

CRTC1 SIM1 ENAM ACAN TNRC6A MAFB PATJ HTT

4.93e-034881588EFO_0007800

Protein segments in the cluster

PeptideGeneStartEntry
TTVATEPTSQETGPE

ESYT3

651

A0FGR9
EEDQPSTSATQSSPA

EP300

1026

Q09472
DDTENPVSPGTSVTE

CFAP54

2346

Q96N23
SSPEDGQVATVSSSP

APBB2

216

Q92870
SQDSASPSSPDETDI

APBB2

266

Q92870
PNEDVDEQTPSTSST

CXorf51A

11

A0A1B0GTR3
PNEDVDEQTPSTSST

CXorf51B

11

P0DPH9
DPTEEPTALTAGQST

ABL2

1001

P42684
TASSPEPEQGSRDSL

BEGAIN

531

Q9BUH8
TPSEGSDTSAAPLSE

ADGRA2

1251

Q96PE1
PTDSETDGSTPVADF

AKAP12

1166

Q02952
QECSTFSPTDSGEEP

CDK18

56

Q07002
PSGSQASSPQSSDVE

GYS2

646

P54840
SVASEPVDQTTGTPT

ALMS1

1361

Q8TCU4
GPDAQKTETPSVSSS

ALMS1

1696

Q8TCU4
STTEPSTSPSNNGEV

AJAP1

251

Q9UKB5
TPSTEEIQSETPGDA

CHAF1B

521

Q13112
PTPSNESTDTASEIG

BAP1

486

Q92560
SDPDSTSQPRSGDSA

DNMBP

1436

Q6XZF7
PAFQTDTTPSETGAT

AQR

1431

O60306
DTTPSETGATSTPEA

AQR

1436

O60306
FSSPSESPDSTVDRQ

ANKRD50

1161

Q9ULJ7
SGDDQSSSSTQPPRE

CECR2

606

Q9BXF3
PSEENVSSSDTGPTS

ADAMTS12

1101

P58397
ADSSQSESPSQPSDA

NFIA

186

Q12857
AESGSESSSQEATPE

RANBP3

351

Q9H6Z4
EESAPTTSPESVSGS

RAD23A

126

P54725
GTTSTDNNNPPSESE

RAB3GAP1

426

Q15042
TVSSATPEPEAGEVS

PCDHA9

841

Q9Y5H5
QNTESPRASAESSPG

ARHGAP39

111

Q9C0H5
LDVSTPSDSVDGPES

INSYN1

116

Q2T9L4
QSTESQSTSGEPATP

MSL3P1

246

P0C860
TVSSATPEPEAGEVS

PCDHA6

841

Q9UN73
TESGSSPSHSPEERQ

KLF9

101

Q13886
SDDDRGTPTSSQPSV

CACNA1F

1696

O60840
TSGEETEETSNPSVS

MUC16

861

Q8WXI7
SDGAESIPTVSFSPS

MUC16

2241

Q8WXI7
DVTSSSSTSFPGPDQ

MUC16

4931

Q8WXI7
SDATPSIATSPGAET

MUC16

10706

Q8WXI7
TPSIATSPGAEATSD

MUC16

11376

Q8WXI7
TSPGAEATSDFPTIT

MUC16

11381

Q8WXI7
DPEGQSPATFSRTST

MUC4

301

Q99102
QDATTPSSVTSPTEG

PBX1

406

P40424
TADSNETTTTSGPPD

PTPRE

26

P23469
QEAVTPSSVTSPTEG

PBX2

406

P40425
TVSSATPEPEAGEVS

PCDHA8

841

Q9Y5H6
TVSSATPEPEAGEVS

PCDHA3

841

Q9Y5H8
GNAPSSESDIDISSP

KAT7

131

O95251
EATSEEVLSPPSDSG

MICAL3

1666

Q7RTP6
AEGDRSSTPSDINSP

KAZN

326

Q674X7
DSVDSGSTTPNSPVS

GRM5

1171

P41594
DETPPTSASDSGSSQ

MAP1A

2496

P78559
SGSSQSDSDVPPETE

MAP1A

2506

P78559
FREAGSTSDSPSSPE

MAFB

306

Q9Y5Q3
EGSSSQEEEGPSTSP

MAGEA4

86

P43358
EEEVSAAGSSSPPQS

MAGEA9

46

P43362
TVPTDGSSRNEETPA

MAVS

376

Q7Z434
STSVQATPDEGPSTS

MAGEE1

221

Q9HCI5
SDSSKTQGPVATEPD

MAP6

446

Q96JE9
SPSLSENPTTDEDDS

LSG1

291

Q9H089
SSLTGESEPQPRSSE

ATP12A

231

P54707
SSLTGESEPQTRSPD

ATP1A1

216

P05023
PSSTQASSVNGTDDE

HOMER2

136

Q9NSB8
ATDGPASETTTLSPE

C3orf18

26

Q9UK00
TNTIEQGPSSSPASD

CCDC190

186

Q86UF4
DPSGTASPQTTTEQA

PCLO

3321

Q9Y6V0
ETPESSLAGSPDTES

PCM1

1926

Q15154
TTSESQDPSSGDPAV

PCNX2

751

A6NKB5
VEPGAPSTATASDIS

PLXNB1

711

O43157
AEAGSPESPESTEIT

IGFBP1

116

P08833
TPGSSNSEATTSVEE

MUC19

7146

Q7Z5P9
SGEAEAPQTTDSPTT

PEAK1

826

Q9H792
SPSSSDTSDEEEGPD

DCAF8

576

Q5TAQ9
ATAPASPTTDSCDGN

FGD4

136

Q96M96
GTREDPTDTPATDSS

DCAF5

896

Q96JK2
EVIPSDTSDTSPEDG

DNAH12

2976

Q6ZR08
VSSSVPASDPSDGQR

POLG

26

P54098
TNPETTTSEGCHSPE

GOLGA6L2

56

Q8N9W4
EPGGPESTEASSTSQ

GLI2

621

P10070
VSDQTSGEPPEPSSS

PITPNM2

276

Q9BZ72
SSEVNPPSDETDSSS

EIF4G2

781

P78344
STEGPSATEVPSASE

ACAN

771

P16112
TADPGTTEDSVTADP

HCG22

221

E2RYF7
TVSSATPEPEAGEVS

PCDHA1

841

Q9Y5I3
TVSSATPEPEAGEVS

PCDHA13

841

Q9Y5I0
ISDEDSPSSPGQTTS

PRTG

1086

Q2VWP7
VPTPSEGTNTSGASE

PCGF2

241

P35227
AASPADSSNSPETET

KAT6A

1251

Q92794
ETPSPDSDSVNSVEG

PIKFYVE

446

Q9Y2I7
AEEGLPTNSTSDSRP

PIKFYVE

1696

Q9Y2I7
SPISDSSQTTTEGPD

HTT

556

P42858
SSQTTTEGPDSAVTP

HTT

561

P42858
TEGPDSAVTPSDSSE

HTT

566

P42858
TDPNISPDQSSGFTT

IGSF10

1356

Q6WRI0
DGSTSPTSTPSEDQE

KDM2B

441

Q8NHM5
QSSSDFEVPSTPEAE

DCLRE1C

646

Q96SD1
SVTPATDGSITPATD

CAMKV

401

Q8NCB2
PSDPSISVSSEQSGA

CDYL

41

Q9Y232
EPSSFQESPSTNTES

CHD6

1716

Q8TD26
GPFSDQSEPAITTSS

CHD6

2591

Q8TD26
TPTQPESFSSGSQDV

CRTC1

161

Q6UUV9
FEVASTSPEDESPGS

CASP9

296

P55211
SSGDEPPSSSSQDEE

TMEM63B

791

Q5T3F8
DALQSSGESSPESAP

CRAMP1

481

Q96RY5
SSSQEPPDEGTSGTD

GON4L

1391

Q3T8J9
VSENDSRPASPSAES

CTR9

1116

Q6PD62
SGEPTSCPATDAETA

DIDO1

96

Q9BTC0
TTQSPESGDPSIFCS

GK

521

P32189
QDSVPPSDSAASDTT

TMEM259

581

Q4ZIN3
GSEDEQESFRPSTSP

CEP192

976

Q8TEP8
SSLTGESEPQTRSPD

ATP1A3

206

P13637
SDSSDSGTSDTDPEP

GPR156

771

Q8NFN8
DIDSSTEDGTEPSPS

EMSY

1301

Q7Z589
TEDGTEPSPSQSSAE

EMSY

1306

Q7Z589
ESPGTEPTANSTVTE

ENAM

236

Q9NRM1
PSESTLESTVAEGSP

DMBT1

51

Q9UGM3
APTESTSQETPEQSD

LIPE

171

Q05469
SGENVASKDDSSPPS

PRDM2

436

Q13029
PFNEEPAETVSSSDT

PLEKHM2

271

Q8IWE5
SPQEEGEGPSSTTES

PLEKHM2

371

Q8IWE5
TSNEVSSSPTPAEGT

MUC17

1311

Q685J3
ESPGEVQASAASPAS

MAP3K1

231

Q13233
IDSGSSVPSDQSPSV

TEX55

226

Q96M34
EATCPSPASSGASQE

SYNRG

1001

Q9UMZ2
GSSSSPEVEAPSSED

AATK

846

Q6ZMQ8
ATAQPPTETGESSQA

GAP43

191

P17677
SAVEGPSAEETPSDT

PLEKHG3

521

A1L390
AESVSDVPPSTGNSA

MTF1

401

Q14872
PEETRSTENGSAPST

RNF126

41

Q9BV68
STENGSAPSTAPTDQ

RNF126

46

Q9BV68
EPSGSETEEDTSSSP

SMIM13

56

P0DJ93
DSVVSSPDPGSASES

SIM1

531

P81133
NPNEDGESSSSSPTE

KIAA1217

1361

Q5T5P2
PSETQSKSESDGNPS

SIX4

281

Q9UIU6
SSRASTDEPPADTQG

SETD1B

1766

Q9UPS6
TSEGPACSPEETASE

MYBPH

6

Q13203
EESPAEPAATATSSN

PPM1B

426

O75688
GTDSDSSPQKSSRDP

PKN1

556

Q16512
SQTPSSHDSDTRDGP

SRCAP

351

Q6ZRS2
ARSGSPAPETTNESV

SETD1A

466

O15047
TAESASGPSEDPSVN

SQSTM1

221

Q13501
STSDTTGEENADPPI

BIRC2

361

Q13490
VDPEGAASTTASSPT

CD300LB

121

A8K4G0
PENPAGFTSTATADS

TXNRD1

41

Q16881
SDSSSVAGPSPNEAA

TCP11

266

Q8WWU5
VPSQDSPGAAESSIS

ZBTB16

251

Q05516
VASSINSPTPTEEGE

TMEM215

131

Q68D42
DTPPTSVTGTSEEQV

SPEG

171

Q15772
PDTEAPATSETSNSR

STBD1

121

O95210
DSGLSTDESEPATTP

SARG

66

Q9BW04
STGEEEASQTPRPSA

SP7

396

Q8TDD2
SDDTGCPSSQSVSPV

SYBU

76

Q9NX95
PSSSPSSIEDQSGTE

PATJ

1336

Q8NI35
SNPSSSAGTPSPEEE

SCAF1

256

Q9H7N4
SDSDTTSPTGQQPSD

ARHGAP25

401

P42331
TPTSTRADVEASPGN

TMEM51

171

Q9NW97
SEEPGSETSDAKSTP

MAPT

56

P10636
LTTAPEAGEVTPSDS

TACC2

2236

O95359
PPSEGSSETSSQSEE

SUCO

1161

Q9UBS9
DPVTGSSENAVSSSE

ZNF507

851

Q8TCN5
SPAATQASVPDDSSS

ZNF835

66

Q9Y2P0
QSSDSCSEEPDSTTP

ZNF687

1081

Q8N1G0
KEAVSSSQGPSDPTD

PMS2CL

86

Q68D20
TPDSSASVERGSTPD

ZNF423

371

Q2M1K9
DGDSEPEETTSDTTP

TMEM72

241

A0PK05
ESPFTQSDEGSSETP

TCHHL1

536

Q5QJ38
SSAGSSEEDDAPEPS

TEX2

951

Q8IWB9
TTTPGLDPAQETTDS

VSIG10L2

741

P0DP72
SEPPTTAAAGATEEE

ZNF579

151

Q8NAF0
TTEPATGPFSETQSS

ZZZ3

296

Q8IYH5
TSDSVSSPQPGASDT

TIMD4

271

Q96H15
EPSTPATTVDNGTSA

TNRC6A

1066

Q8NDV7
ASSTPGPEEVDSASA

ZFPL1

161

O95159
TPGTTAVSSNRDPED

nan

236

Q8N7P7
ENAPESSSSAPGSEE

TBC1D2

6

Q9BYX2
SSSSAPGSEESARDP

TBC1D2

11

Q9BYX2
SSPVSPVDSLGTSEE

TWIST2

6

Q8WVJ9
QRQASPETSASPDGS

GOLGB1

3006

Q14789
TEESTAFPGSPASTQ

MUC12

2911

Q9UKN1